written on 10.03.2014
Tags:
,

With Solvadi in the mix, the FDA's class of 2013 is set for chart-busting sales

TAGS: ,

The number of new drugs approved by the FDA last year may have been down considerably but some of them were humdingers. Eight are projected to hit blockbuster status 5 years out, and the entire group of 33 is forecast to have fifth-year projected sales of $25.4 billion. That is 50% more than the record breaking group of 43 drugs approved in 2012.

Latest Report